Skip to content

The Corona and COVID-19 Study in Telemark and Agder

The Corona and COVID-19 Study in Telemark and Agder - COVITA

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04514003
Acronym
COVITA
Enrollment
1200
Registered
2020-08-14
Start date
2020-07-01
Completion date
2035-12-31
Last updated
2024-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Keywords

Immunity, Risk factors, Test-negative design, Population controls

Brief summary

Through SARS-CoV-2 IgG testing of PCR positive and negative cases the study will follow the COVID-19 immune response by monitoring the SARS-CoV-2 IgG antibody levels over a period of two years. Further, risk factors will be identified by the use of the test-negative design including population controls, allowing comparison of participants with positive and negative tests, and with population controls (triangulation). Special emphasis will be on high risk groups in general and on different occupational, environmental and socio-economic groups in particular. Finally, severity of illness, deaths and the use of health care during will be assessed using national register data from Telemark and Agder.

Detailed description

Objectives The main objectives are: 1. Monitor the incidence of COVID-19 and the development of the SARS-CoV-2-IgG levels of cases in Agder and Telemark over a period of two years (WP1). 2. Identify risk factors for COVID-19 by comparison of SARS-CoV-2 antibody positive and negative cases in Telemark and Agder, and comparison of these groups separately with population controls (WP2). 3. The incidence of neurocognitive symptoms and fatigue in COVID-19 patients (WP3). 4. Investigation of severity, death and the use of health care for the COVID-19 patients based on data from national registers (WP4). The main exposures are (WP1-3): * Infection (mild, severe) with COVID-19. * Occupational risk factors assessed by occupational codes (ISCO88) and job exposure matrix categorisation. * Environmental risk factors (road traffic outside bedroom window, travel by foot or bicycle alongside busy roads, and the use of a fireplaces in residential homes. Further, estimated measurements of air pollution may be linked to participants' home address. * Socioeconomic status; age, sex, comorbidity, medication use, lifestyle factors (smoking, BMI, physical activity, others), geographic region/municipality, education and income.

Interventions

None listed

Sponsors

Sorlandet Hospital HF
CollaboratorOTHER_GOV
Norwegian Institute of Public Health
CollaboratorOTHER_GOV
London School of Hygiene and Tropical Medicine
CollaboratorOTHER
Leiden University
CollaboratorOTHER
Aalborg University
CollaboratorOTHER
Sykehuset Telemark
Lead SponsorOTHER_GOV

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
Yes

Inclusion criteria

* Age 18 - 85 years * Performed SARS-CoV-2 PCR test

Exclusion criteria

* Non-Norwegian speakers. * Deceased * inability to answer questionnaire due to dementia or similar conditions

Design outcomes

Primary

MeasureTime frameDescription
SARS-CoV-2 IgG antibody level2020-2023Serum Levels of SARS-CoV-2 IgG antibody and the Development of these over a two years period
Risk factors for COVID-192020-2026Different risk factors (age, sex, education, comorbidity, occupational and environmental exposure will be assessed

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026